GlassScriptPhysician profile
Deborah K Davis
NPI 1336114669
$1,189.42
in general payments reported to CMS, 2019-2025
17 companies · $312 in 2025
The $312 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $27.17 · 2021: $76.11 · 2022: $226 · 2023: $192 · 2024: $207 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $230.93 | 2019-2025 | Onyda Xr, Dyanavel Xr |
| Corium, LLC | $208.78 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $188.73 | 2024-2025 | Qelbree |
| Boston Scientific Corporation | $139.60 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $71.26 | 2020-2022 | |
| Cranial Technologies, INC | $69.91 | 2019-2025 | Doc Band |
| Sobi, INC | $58.00 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $39.35 | 2019-2025 | Gardasil 9 |
| Neos Therapeutics, LP | $28.18 | 2024-2025 | Cotempla Xr-Odt |
| Ars Pharmaceuticals Operations, INC. | $24.14 | 2025 | Neffy |
| Pfizer INC. | $23.20 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.41 | 2025 | |
| Sanofi Pasteur INC. | $21.70 | 2022 | |
| Ironshore Pharmaceuticals INC. | $17.54 | 2024 | |
| Noven Therapeutics, LLC | $17.00 | 2025 | Xelstrym |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $14.95 | 2025 | |
| Seqirus USA INC | $13.74 | 2023 | Flucelvax Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.